Symbiotec Pharmalab Limited, a active public limited company, was established on 20 September 2002 in Mhow, Madhya Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232MP2002PTC015293. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹10.94 Cr.
Formerly known as Symbiotec Pharmalab Limited. It upholds a compliant status. Employing 1,330 professional, Its leadership includes Shankar Gopalakrishnan (Nominee Director), Rohit Brijmohan Mantri (Nominee Director), Buggana Hariharnath (Nominee Director). Past directors included Varinder Sohanlal Ahuja, Arun Mangilal Luharuka, Sumit Gupta. It holds ₹556.47 Cr open charges and ₹395.55 Cr settled loans. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at 385/2, Pigdamber,, Rau, Mhow, Madhya Pradesh, 453331.
U24232MP2002PLC015293
015293
20 September 2002
₹30.00 Cr
₹10.94 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Symbiotec Pharmalab Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shankar Gopalakrishnan | Nominee Director | 06 Dec 2018 | Current |
| Rohit Brijmohan Mantri | Nominee Director | 06 Dec 2018 | Current |
| Buggana Hariharnath | Nominee Director | 16 Sep 2024 | Current |
| Anil Kumar Satwani | Managing Director | 20 Sep 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jan 2012 | Past |
| Pramod Abcsdd | Alternate Director | 19 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2019 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 01 Oct 2012 | Past |
| Pramod Abcsdd | Alternate Director | 21 Oct 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Symbiotec Pharmalab Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 20.39% increase. The company also saw a substantial improvement in profitability, with a 492.54% increase in profit. The company's net worth Soared by an impressive increase of 13.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Symbiotec Pharmalab had a promoter holding of 25.08% and a public holding of 74.92%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,564,725,000.00
₹3,955,538,548.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2025 | State Bank Of India | ₹0.03 M | Open |
| 27 Sep 2024 | Sbicap Trustee Company Limited | ₹555.98 Cr | Open |
| 06 Feb 2019 | Yes Bank Limited | ₹4.90 M | Open |
| 28 Jul 2022 | Axis Bank Limited | ₹1.99 Cr | Satisfied |
| 01 Mar 2018 | Hdfc Bank Limited | ₹1.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Symbiotec Pharmalab has a workforce of 1330 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Symbiotec Pharmalab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiotec Pharmalab's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Sbicap Trustee Company Limited of Rs. 555.98 Cr registered on 27 Sep 2024 with Charge ID 100986513 was modified on 25 Sep 2025. was recorded as a recent event.
A charge with State Bank Of India amounted to Rs. 0.00 Cr with Charge ID 101139783 was registered on 23 Jul 2025. was recorded as a recent event.
A charge registered on 28 Jul 2022 via Charge ID 100604774 with Axis Bank Limited was fully satisfied on 06 Jun 2025. was recorded as a recent event.
A charge registered on 21 Jul 2003 via Charge ID 90205950 with State Bank Of India was fully satisfied on 28 Oct 2024. was recorded as a recent event.
The activity A charge with Sbicap Trustee Company Limited amounted to Rs. 555.98 Cr with Charge ID 100986513 was registered on 27 Sep 2024. was completed.
Symbiotec Pharmalab Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records. was recorded as a recent event.
Private equity firm InvAscent plans to list five portfolio companies in the health and pharmaceutical sectors over the next 24–36 months, providing exit opportunities for the investor..
The stake sale deal with Baring PE Asia may value Symbiotec Pharmalab at $300-350 million, with majority investor Actis standing to make $210-245 million.
The CIN of Symbiotec Pharmalab Limited is U24232MP2002PLC015293.
Symbiotec Pharmalab Limited is headquartered at 385/2, Pigdamber,, Rau, Mhow, Madhya Pradesh, 453331.
Symbiotec Pharmalab Limited was incorporated on 20 September 2002.
The current directors of Symbiotec Pharmalab Limited are
The primary industry of Symbiotec Pharmalab Limited is Manufacturing.
Symbiotec Pharmalab Limited is unlisted.
The authorized capital of Symbiotec Pharmalab Limited is ₹30.00 Cr, and the paid-up capital is ₹10.94 Cr.
The compliance status of Symbiotec Pharmalab Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX